Shopping Cart
- Remove All
- Your shopping cart is currently empty
IALYLQQNW is a specific nonapeptide sequence derived from the Epstein-Barr virus (EBV) encoded tumor-associated latent membrane protein 1 (LMP1). As a potential T-cell epitope, IALYLQQNW has the ability to activate EBV-specific cytotoxic T lymphocytes (CTLs), which can recognize and eliminate EBV-infected cells expressing LMP1. This peptide plays a vital role in the immune response against EBV-associated tumors and is utilized in research on Hodgkins disease and nasopharyngeal carcinoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | IALYLQQNW is a specific nonapeptide sequence derived from the Epstein-Barr virus (EBV) encoded tumor-associated latent membrane protein 1 (LMP1). As a potential T-cell epitope, IALYLQQNW has the ability to activate EBV-specific cytotoxic T lymphocytes (CTLs), which can recognize and eliminate EBV-infected cells expressing LMP1. This peptide plays a vital role in the immune response against EBV-associated tumors and is utilized in research on Hodgkins disease and nasopharyngeal carcinoma. |
Molecular Weight | 1148.31 |
Formula | C55H81N13O14 |
Cas No. | 610268-80-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.